April 24, 2026 FDA Accelerates Review of Psychedelic Drugs for Mental Health with Priority Review Vouchers for Compass, Usona, and Transcend Therapeutics
April 23, 2026 Title: New Medicare Coverage Pathway Aims to Speed Access to Breakthrough Medical Devices
April 23, 2026 Kennedy’s Shifting Stance on Vaccines and MAHA Agenda Sparks Debate in Senate Hearings
April 22, 2026 Overcoming Resistance and RevMed’s Next Drug: RM-055 as a Catalytic Inhibitor in the RAS Inhibitor Arms Race
